Beauty-from-within: In-Cosmetics Global spotlights collagen alternatives, exosome innovation
The In-Cosmetics Global 2026 exhibition highlights a strategic pivot in beauty-from-within ingredients, focusing on novel collagen alternatives, exosomes, and microbiome-focused actives to meet escalating consumer demand for advanced nutraceuticals.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 15 April 2026
Key exhibitors at In-Cosmetics Global 2026 are showcasing an advanced suite of beauty-from-within ingredients, signalling a significant shift in nutraceutical formulation. The event, a critical barometer for industry trends, featured a strong emphasis on collagen alternatives, exosome technology, and microbiome-centric actives. This indicates a market maturation beyond traditional collagen peptides towards more sophisticated, scientifically backed solutions. Suppliers including ExoLab Italia, Mibelle Biochemistry, and Activ’Inside demonstrated ingredients targeting skin, hair, and anti-ageing applications, underscoring ongoing innovation in this high-growth sector.
The ingredient spotlight at In-Cosmetics Global was particularly on bioactive collagen peptides, lactoferrin, and precision-fermented proteins. These compounds offer enhanced bioavailability and targeted efficacy, addressing specific consumer concerns such as skin hydration (hyaluronic acid), pigmentation control, and improved UV protection. Botanical extracts continue their strong market presence, with Monteloeder by Suannutra and Tabia Botanicals presenting plant-based solutions alongside established players like Symrise and BTC Europe. This blend of novel and established ingredients points to a diversified sourcing strategy for brand owners aiming for comprehensive product portfolios.
The focus on exosomes and microbiome-modulating ingredients represents a cutting-edge development, moving beyond general gut health to specific skin microbiome benefits. This segment demands stringent scientific validation and clear communication to consumers regarding efficacy and the underlying biological mechanisms. Brands adopting these ingredients will require robust R&D investment and strong regulatory compliance strategies to navigate novel food or supplement classifications. The prominence of these advanced actives at such a prominent industry event confirms their trajectory from niche science to mainstream ingredient offerings within the next 18 months.
What this means for United Kingdom
UK brand owners need to initiate strategic ingredient reviews immediately, targeting Q3 2026 for reformulation decisions. The emergence of collagen alternatives and exosome technology, alongside microbiome actives, will elevate raw material costs by an estimated 10-20% for cutting-edge formulations. Compliance teams must engage with the FSA regarding novel food classifications for these ingredients, particularly exosomes, to ensure market access by early 2027. Manufacturers should anticipate increased MOQs from specialist suppliers and longer lead times for sourcing these advanced compounds. Early engagement with distributors and contract manufacturers specializing in complex ingredient handling will be critical for maintaining competitive differentiation against larger firms already investing in these areas, especially as demand from retailers like Boots and Holland & Barrett for proven efficacy grows.
The sustained interest in vitamins, carotenoids, and omega-3s for beauty-from-within applications underscores the ongoing demand for established, scientifically-proven nutrients. This provides opportunities for brands to fortify existing product lines with enhanced delivery systems or more bioavailable forms. However, the commercial imperative remains to integrate innovative ingredients where consumer perception of efficacy and premium value is strongest.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.